CCND2 and breast carcinoma: The weakness of this study is the cohort of 93 samples of Taiwanese breast cancer patients were analyzed for methylation of CCND2 gene is not the same with the cohort of 18 patients were analyzed in patients’ plasma circulating cell free DNA.